RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
10-Butyl Ether Minocycline Reduced High Alcohol Consumption in a Dependence Mouse Model
Panthagani, P., Shaik, A. A., Liu, X., Shanmugam, S., Blough, B., Reid, T. W., Pauli, E., Benton, T., Henderson, G. I., Bailoo, J. D., & Bergeson, S. E. (2024). 10-Butyl Ether Minocycline Reduced High Alcohol Consumption in a Dependence Mouse Model. Alcoholism Treatment Quarterly. https://doi.org/10.1080/07347324.2024.2406551
Alcohol use disorder (AUD) poses a significant public health concern, with limited, high-efficacy, treatment options. Our lab has demonstrated that minocycline, an antibiotic with neuroprotective and immunomodulatory properties, is effective in reducing alcohol consumption in rodent models. We then synthesized antimicrobial-free minocycline derivatives to utilize their neuroprotective and immunomodulatory activities while mitigating antibiotic-related side effects. 10-Butyl Ether Minocycline (BEM) was chosen as a lead molecule based on efficacy and physicochemical properties from the library of compounds synthesized. Here, we report that BEM significantly reduced alcohol consumption in the Chronic Intermittent Ethanol (CIE) mouse model of alcohol dependence.
